Identifying Predictors for Hypoplastic Aortic Arch (HAA) in Pediatric Patients with Complex Coarctation of the Aorta

Ying Lyu1, Lu Tian1, Bin Qin1

  • 1Department of Radiology Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders. Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China.

PubMed

Insights

Hypoplastic ascending aorta (HAA) is linked to severe coarctation of the aorta (CoA) and other cardiovascular issues in children. Identifying HAA can improve diagnosis and treatment for complex CoA patients.

Area of Science:

  • Cardiovascular Medicine
  • Pediatric Cardiology
  • Medical Imaging

Background:

  • Hypoplastic ascending aorta (HAA) is a significant risk factor in patients with complex coarctation of the aorta (CoA).
  • Understanding the associations between HAA and other cardiovascular factors is crucial for managing complex CoA.

Purpose of the Study:

  • To explore the relationship between HAA and other cardiovascular factors in children with complex CoA.
  • To identify risk factors associated with HAA in this patient population.

Main Methods:

  • Retrospective analysis of 103 patients with complex CoA, diagnosed via CT angiography and echocardiography.
  • Measurement of aortic diameter at six levels; severe coarctation defined by coarctation site to diaphragmatic level ratio (CDR) < 50%.
  • Assessment of correlations and logistic regression to identify HAA risk factors.

Main Results:

  • The HAA group (48 patients) showed higher incidences of patent ductus arteriosus (PDA), severe coarctation (CDR < 50%), and collateral arteries compared to the non-HAA group (55 patients).
  • Collateral arteries were identified as significant risk factors for aortic arch hypoplasia, severe coarctation, and left heart dysfunction.
  • Aortic arch size correlated positively with age and negatively with severe coarctation, VSD, collateral arteries, and left heart dysfunction.

Conclusions:

  • HAA is prevalent in complex CoA patients and associated with critical cardiovascular anomalies.
  • Findings enhance understanding of HAA's role in complex CoA, potentially improving diagnostic and therapeutic strategies.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...